• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物透过基于磷脂囊泡的屏障:3. 药物-膜相互作用的表征以及搅拌对屏障完整性和通透性的影响。

Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.

作者信息

Flaten Gøril Eide, Skar Merete, Luthman Kristina, Brandl Martin

机构信息

University of Tromsø, Institute of Pharmacy, Department of Pharmaceutics & Biopharmaceutics, N-9037 Tromsø, Norway.

出版信息

Eur J Pharm Sci. 2007 Mar;30(3-4):324-32. doi: 10.1016/j.ejps.2006.11.017. Epub 2006 Dec 9.

DOI:10.1016/j.ejps.2006.11.017
PMID:17204409
Abstract

Recently, we reported on the development and structural characterization of a phospholipid vesicle based barrier useful for medium throughput screening of passive drug permeability. Here, we investigate the physical and functional integrity of the phospholipid vesicle based barriers to agitation by stirring or shaking, and whether agitation affects drug permeability of sulpiride, metoprolol and testosterone. In addition, three drugs (caffeine, naproxen and sulphasalazine) which were shown in a previous study to affect the electrical resistance of the barriers, were investigated for their influence on the permeability of a simultaneously applied hydrophilic marker (calcein), and on the thermotropic phase transition of the phospholipid bilayers using differential scanning calorimetry (DSC). Electrical resistance measurements indicated that the barriers should withstand shaking speeds up to 150rpm without losing their integrity, but significant release of phospholipids from the membrane barriers to the donor and acceptor chambers was observed under agitation >or=150rpm. When using agitation up to 100rpm no increase in permeability was observed for sulpiride, metoprolol and testosterone. The phospholipid vesicle-based barrier thus differ from other permeability models in that agitation does not lead to an increase in permeability, not even for highly lipophilic drugs such as testosterone. This is explained by the different morphology of the vesicle-based barrier which is containing a 100microm thick layer of mostly aqueous compartments immobilised within a matrix of phospholipids vesicles. Sulphasalazine and naproxen were shown to decrease the electrical resistance and increase the permeability of the hydrophilic marker calcein. The DSC experiments showed that these two drugs probably interact with the head groups of the phospholipids. In contrast, caffeine gave an increase in electrical resistance and a decrease in permeability of calcein. From the DSC experiments no signs of interaction of caffeine with the phospholipid bilayer could be observed.

摘要

最近,我们报道了一种基于磷脂囊泡的屏障的开发及其结构表征,该屏障可用于被动药物渗透性的中通量筛选。在此,我们研究了基于磷脂囊泡的屏障在搅拌或振荡下的物理和功能完整性,以及搅拌是否会影响舒必利、美托洛尔和睾酮的药物渗透性。此外,在先前的一项研究中显示三种药物(咖啡因、萘普生和柳氮磺胺吡啶)会影响屏障的电阻,因此研究了它们对同时施加的亲水性标记物(钙黄绿素)渗透性的影响,以及使用差示扫描量热法(DSC)对磷脂双层热致相变的影响。电阻测量表明,屏障在高达150rpm的振荡速度下应能保持完整性,但在振荡速度≥150rpm时,观察到有大量磷脂从膜屏障释放到供体和受体室中。当使用高达100rpm的振荡时,舒必利、美托洛尔和睾酮的渗透性没有增加。因此,基于磷脂囊泡的屏障与其他渗透性模型不同,因为振荡不会导致渗透性增加,即使对于像睾酮这样的高度亲脂性药物也是如此。这可以通过基于囊泡的屏障的不同形态来解释,该屏障包含一个100微米厚的主要为水相隔室的层,固定在磷脂囊泡基质中。柳氮磺胺吡啶和萘普生被证明会降低电阻并增加亲水性标记物钙黄绿素的渗透性。DSC实验表明,这两种药物可能与磷脂的头部基团相互作用。相比之下,咖啡因会导致电阻增加和钙黄绿素渗透性降低。从DSC实验中未观察到咖啡因与磷脂双层相互作用的迹象。

相似文献

1
Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.药物透过基于磷脂囊泡的屏障:3. 药物-膜相互作用的表征以及搅拌对屏障完整性和通透性的影响。
Eur J Pharm Sci. 2007 Mar;30(3-4):324-32. doi: 10.1016/j.ejps.2006.11.017. Epub 2006 Dec 9.
2
Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.药物透过基于磷脂囊泡的屏障 2. 屏障结构、储存稳定性及对pH变化的稳定性的表征
Eur J Pharm Sci. 2006 Jul;28(4):336-43. doi: 10.1016/j.ejps.2006.03.008. Epub 2006 Apr 18.
3
Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.药物透过基于磷脂囊泡的屏障:一种研究被动扩散的新方法。
Eur J Pharm Sci. 2006 Jan;27(1):80-90. doi: 10.1016/j.ejps.2005.08.007. Epub 2005 Oct 24.
4
In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.采用基于磷脂囊泡的屏障对含有难溶性药物化合物的熔融挤出制剂进行体外渗透筛选。
J Pharm Pharmacol. 2010 Nov;62(11):1591-8. doi: 10.1111/j.2042-7158.2010.01172.x.
5
Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.药物透过基于磷脂囊泡的屏障 4. 表面活性剂、助溶剂和pH变化对屏障完整性及药物渗透性的影响。
Eur J Pharm Sci. 2008 Jul 3;34(2-3):173-80. doi: 10.1016/j.ejps.2008.04.001. Epub 2008 Apr 15.
6
Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay.模拟肠液在基于磷脂囊泡的药物渗透测定中的应用。
Int J Pharm. 2012 Jan 17;422(1-2):52-8. doi: 10.1016/j.ijpharm.2011.10.026. Epub 2011 Oct 17.
7
In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants.基于磷脂囊泡的渗透测定法中测定疏水性药物的体外渗透度:非离子表面活性剂的影响。
J Pharm Pharmacol. 2011 Aug;63(8):1022-30. doi: 10.1111/j.2042-7158.2011.01301.x. Epub 2011 Jun 15.
8
Surface-dependent transitions during self-assembly of phospholipid membranes on mica, silica, and glass.磷脂膜在云母、二氧化硅和玻璃上自组装过程中的表面依赖性转变。
Langmuir. 2004 Nov 9;20(23):10129-37. doi: 10.1021/la048811u.
9
Phospholipid subclass specific alterations in the passive ion permeability of membrane bilayers: separation of enthalpic and entropic contributions to transbilayer ion flux.膜双层被动离子通透性中磷脂亚类的特异性改变:跨膜离子通量中焓和熵贡献的分离。
Biochemistry. 1998 Feb 24;37(8):2346-55. doi: 10.1021/bi9725172.
10
Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity?尼美舒利与膜模型系统的相互作用:尼美舒利的线粒体毒性是否涉及膜物理效应?
Toxicol In Vitro. 2011 Sep;25(6):1215-23. doi: 10.1016/j.tiv.2011.05.014. Epub 2011 May 27.

引用本文的文献

1
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies.用于工业药物开发的市售无细胞渗透性测试:通过减少体内研究提高可持续性
Pharmaceutics. 2023 Feb 9;15(2):592. doi: 10.3390/pharmaceutics15020592.
2
Alkaloids Modulate the Functioning of Ion Channels Produced by Antimicrobial Agents via an Influence on the Lipid Host.生物碱通过影响脂质宿主来调节抗菌剂产生的离子通道的功能。
Front Cell Dev Biol. 2020 Jun 30;8:537. doi: 10.3389/fcell.2020.00537. eCollection 2020.
3
Liposomes for topical use: a physico-chemical comparison of vesicles prepared from egg or soy lecithin.
用于局部给药的脂质体:由鸡蛋卵磷脂或大豆卵磷脂制备的囊泡的物理化学比较
Sci Pharm. 2013 Jul 14;81(4):1151-66. doi: 10.3797/scipharm.1305-11. Print 2013 Oct-Dec.
4
In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil.在流体动力学控制下的原位人工膜渗透测定法:华法林和维拉帕米的渗透-pH 曲线。
Pharm Res. 2010 Aug;27(8):1644-58. doi: 10.1007/s11095-010-0150-6. Epub 2010 May 7.
5
Modeling kinetics of subcellular disposition of chemicals.化学物质亚细胞分布动力学建模。
Chem Rev. 2009 May;109(5):1793-899. doi: 10.1021/cr030440j.